SCHEMBL24306830

SCHEMBL24306830

COC(=O)c1ccc2c(c1)NC(=O)C1(CN(C)C1)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.50
POLB P06746 2/20 0.49
HPGD P15428 1/20 0.49
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 2/20 0.43
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 1/20 0.40
NISCH Q9Y2I1 1/20 0.40
CRBN Q96SW2 3/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
DDB1 Q16531 2/20 0.38
NPC1 O15118 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24306982 0.88 ALOX5 (0.48) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL30035530 0.87 ALOX5 (0.54) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL8004920 0.87 ALOX5 (0.54) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24306375 0.87 ALOX5 (0.47) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24306310 0.87 ALDH1A1 (0.46) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24307595 0.86 ALOX5 (0.51) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24307071 0.86 ALOX5 (0.46) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24306813 0.86 POLB (0.52) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24306851 0.85 ALOX5 (0.52) ALOX5POLBHPGDALDH1A1KDM4E
SCHEMBL24306786 0.85 ALOX5 (0.52) ALOX5POLBHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-11-16 US disclosed
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-11-16 US disclosed
EP-4219461-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF Medshine Discovery Inc. (CN) 2023-08-02 EP disclosed
WO-2022063094-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF 南京明德新药研发有限公司 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF CYP3A7, UGT2B7, SFPQ ALOX5 2582/4885POLB 3308/4885HPGD 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.